Teckro Press Coverage in publications like the Financial Times, the Irish Times, Silicon Republic, Fierce Biotech,  Think Business, Fora, or the Limerick Post

Press coverage Teckro | Have a Study Question ? Teckro the Answer

The Limerick Post outlines the results of industry research by Teckro and Tufts Center for the Study of Drug Development (CSDD) into investigative site protocol administration referencing practices.

Protocol instruction by investigative site staff is through unsophisticated approaches – Teckro press coverage by The Limerick Post.

Teckro Tufts CSDD Research Results | Press Coverage Limerick Post

New Industry Research Finds that Investigative Sites Use Unsophisticated Approaches to Access Protocol Instructions, Despite Availability of Newer Technologies

With the conservative pharma industry showing signs that it can adapt under pressure, clinical trials are finally being pushed into the 21st Century. Teckro CEO Gary Hughes explains how COVID-19 is reshaping the industry and why sponsors can no longer ignore the advantages of modern technology.

Teckro CEO Gary Hughes talks to PharmaTimes about how COVID-19 has reshaped the pharma industry, and why sponsors must adopt modern solutions.

Teckro is supporting many COVID-19 trials in the race to find a treatment. In this Irish Times feature, CEO Gary Hughes explains how Teckro is making clinical trials simpler so they run faster. And he talks about why the pandemic highlights the need to modernize clinical research. 

Teckro is supporting many COVID-19 drug trials. CEO Gary Hughes explains to the Irish Times how Teckro is making clinical trials simpler so they run faster.

Irish Tech in COVID-19 Drug Trials | Press Coverage Irish Times | Teckro 

Irish Tech in Use in COVID-19 Drug Trials

There are many inefficiencies in the way clinical trials are run globally; one of the primary challenges is recruiting the right patients to the right trial. Teckro CEO Gary Hughes shares his insights into how to drive efficiencies in clinical trials of the future.

Teckro CEO Gary Hughes shares his insights with Pharmaceutical Technology on how to drive efficiencies in clinical trials of the future.

What Does the Future Hold for Clinical Trial Recruitment? | Teckro

What Does the Future Hold for Clinical Trial Recruitment?

The Limerick Post writes about Teckro's unprecedented user adoption rates and the introduction of its new products. 

Teckro Press Coverage in the Limerick Post: Limerick based healthcare startup given major boost. Have a study question? Teckro the answer.

Start Up given Major Boost | Press Coverage Limerick Post |Teckro

Limerick-based Healthcare Startup Given Major Boost

Anita Callan (Teckro VP of Product) discusses her experiences designing with the end user in mind.

Teckro Press Coverage in Fora: Design at the heart of company. Have a study question? Teckro the answer.     

Design at Heart | Press coverage Fora | Teckro

Why Putting Design at the Heart of a Company Can Help it Thrive

Silicon Republic covers Teckro's engineering job expansion in Dublin.

Teckro Press Coverage in Silicon Republic: Dublin engineering hub expansion. Have a study question? Teckro the answer.

Engineering Hub Expansion | Press coverage Silicon Republic | Teckro

Teckro Announces 45 Dublin Jobs as it Expands Engineering Hub

CEO Gary Hughes explains how Teckro is transforming clinical trials for the world’s leading pharmaceutical and emerging biotech firms.

Teckro Press Coverage in Think Business: CEO Appetite for Disruption. Have a study question? Teckro the answer.     

CEO Appetite for Disruption | Press Coverage Think Business | Teckro

Teckro CEO Gary Hughes’ Appetite For Disruption

FierceBiotech writes about Teckro's leadership appointments, including Brendan Buckley as Chief Medical Officer.

Teckro Press Coverage in Fierce Biotech: Hiring Spree netx ex icon CMO. Have a study question? Teckro the answer.

Hiring Spree | Press coverage Fierce Biotech | Teckro

The Financial Times quotes Teckro CEO Gary Hughes on the potential for technology to reduce costs in clinical trials.

Teckro Press Coverage in the Financial Times: Alphabet and Apple take divergent paths in Health. Have a study question? Teckro the answer.

Alphabet and Apple | Press Coverage Financial Times | Teckro

Alphabet and Apple Take Divergent Paths in Health

The Irish Times covers Teckro's Series C funding round and its immediate plans to double its workforce.

Teckro Press Coverage in the Irish Times: Raising 25 million in funding. Have a study question? Teckro the answer.     

25 Million in Funding | Press coverage Irish Times | Teckro

Limerick-based Teckro Raises $25m in Funding

Silicon Republic covers Teckro's Series A funding round and its plans to expand its product development team.

Teckro Press Coverage in Silicon Republic: Raising 6 million in funding. Have a study question? Teckro the answer.   

6 Million in Funding | Press coverage Silicon Republic | Teckro

Limerick’s Teckro Raises $6m in Round Led by Founders Fund

Every clinical trial starts with a question